7A
Valuation Multiples Analysis
Carter's, Inc. (CRI) is currently trading at a significant discount to its historical valuation norms, reflecting a cautious stance from the equity markets. The company’s forward P/E ratio of 10.4x represents a nearly 39% contraction from its five-year average of 17.0x. This compression is mirrored across other key metrics, with the EV/EBITDA multiple sitting at 8.3x compared to a historical 10.0x. While these levels might typically signal an undervalued opportunity, the 'contracting' valuation trend suggests that investors are actively repricing the stock downward, likely due to concerns regarding long-term birth rate trends and inflationary pressures on the core consumer demographic.
When viewed against its industry peers, the valuation profile presents a complex picture. CRI trades at a massive 59% discount to the peer median P/E of 25.4x, yet it maintains a 35.4% premium on a Price-to-Book (P/B) basis. This divergence indicates that while the market is skeptical of CRI's immediate earnings growth potential relative to the broader apparel sector, it still assigns a premium to the company's underlying asset base and brand equity. The relatively narrow 10.4% discount on an EV/EBITDA basis compared to peers suggests that when accounting for debt and depreciation, CRI’s operational cash flow is valued more in line with the industry than its bottom-line earnings would suggest.
Key Findings
- Significant historical P/E compression of 38.7% relative to the 5-year average suggests a fundamental shift in market sentiment or a pricing in of cyclical headwinds.
- The stark 59% P/E discount to peers contrasts with a 35.4% P/B premium, indicating the market values Carter's brand and balance sheet strength more than its current earnings trajectory.
- An EV/EBITDA multiple of 8.3x (10.4% below peer median) provides a more grounded valuation floor than the P/E ratio, suggesting the company is at a 'Slight Discount' rather than deep value territory.
Company Valuation Highlights
CRI:
At 10.4x P/E, Carter's is trading well below its historical 17.0x anchor, signaling that the market expects subdued growth; however, the 2.26x P/B ratio confirms that the company still commands a premium for its market-leading position compared to the 1.67x peer median.
| Company | P/E | Hist Avg | Fwd P/E | PEG | P/B | EV/EBITDA | P/S | Position |
|---|---|---|---|---|---|---|---|---|
| CRI | 10.4x | 17.0x | 10.7x | 8.14x | 2.26x | 8.3x | 0.68x | Fair Value |
Historical Percentile Position
Where current multiples sit relative to full historical range (higher percentile = more expensive vs history)
| Company | P/E %ile | P/E Range | P/B %ile | P/B Range | EV/EBITDA %ile | P/S %ile |
|---|---|---|---|---|---|---|
| CRI | 0th | 10.4x - 37.1x | 0th | 2.26x - 6.52x | 0th | 0th |
Peer Valuation Comparison
How each company's valuation compares to its industry peers
CRI vs 9 Peers
Slight DiscountP/E Ratio
10.4x
Peer Median: 25.4x
(-59.0%)
P/B Ratio
2.26x
Peer Median: 1.67x
(+35.4%)
EV/EBITDA
8.3x
Peer Median: 9.2x
(-10.4%)
P/S Ratio
0.68x
Peer Median: 1.15x
(-41.0%)
View all 9 peers
| Peer | P/E | P/B | EV/EBITDA | P/S | Market Cap |
|---|---|---|---|---|---|
| CRI | 10.4x | 2.26x | 8.3x | 0.68x | - |
| BH | 557.8x | 2.01x | 24.6x | 3.04x | $1.2B |
| GIII | 25.4x | 0.69x | 17.6x | 0.41x | $1.2B |
| LOT | N/A | N/A | N/A | 1.33x | $832M |
| HDL | 45.9x | 2.48x | 9.2x | 1.15x | $946M |
| LVWR | N/A | 7.72x | N/A | 19.03x | $477M |
| GRBK | 8.9x | 1.68x | 7.3x | 1.43x | $3.0B |
| LEG | 7.2x | 1.67x | 5.6x | 0.38x | $1.6B |
| THRM | 31.8x | 1.36x | 5.8x | 0.67x | $976M |
| GES | 10.8x | 0.55x | 14.2x | 0.28x | $877M |
| Peer Median | 25.4x | 1.67x | 9.2x | 1.15x | - |
7B
Enterprise Value Analysis
Carter’s, Inc. (CRI) currently carries an Enterprise Value (EV) of $2.65 billion, a figure that significantly exceeds its market capitalization of $1.27 billion. This discrepancy highlights a capital structure where a substantial portion of the firm's total value is comprised of debt obligations rather than equity. With total debt standing at $1.13 billion against a cash position of $412.9 million, the resulting net debt of $717.3 million represents nearly 27% of the total enterprise value. For investors, this implies that the business is more capital-intensive than its market cap suggests, and valuation must be viewed through the lens of its total obligations to both creditors and shareholders.
From a multiple perspective, CRI is trading at an EV/EBITDA of 8.3x and an EV/Sales ratio of 0.93x. The sub-1.0x sales multiple is particularly noteworthy, as it suggests the market is pricing the company at a discount to its annual revenue generation, likely reflecting concerns over long-term growth prospects in the competitive children's apparel segment. While an 8.3x EBITDA multiple is not excessive for a market leader, the valuation reflects a cautious stance from the investment community regarding the sustainability of margins and the impact of the company's leverage on future equity returns.
Key Findings
- The Enterprise Value of $2.65B is more than double the equity value, indicating that creditors hold a significant claim on the company's assets and cash flows.
- An EV/Sales multiple of 0.93x suggests a conservative valuation of the company's top-line revenue, often indicative of a mature or slow-growth industry outlook.
- The 8.3x EV/EBITDA multiple represents a moderate valuation that balances Carter's dominant market share against the cyclical risks inherent in the retail sector.
Leverage Assessment
Carter’s leverage is classified as 'Moderate' with a Net Debt/EBITDA ratio of 2.24x. While this level of indebtedness is manageable and common for established retailers with steady cash flows, it does limit the company's financial flexibility compared to debt-free peers. The current debt load requires consistent operational performance to service interest obligations and maintain the current dividend policy. Investors should monitor this ratio closely; while not in a high-risk zone, any significant contraction in EBITDA could quickly push leverage into a more aggressive tier, potentially impacting the company's credit profile and equity valuation.
| Company | Market Cap | EV | Net Debt | EV/EBITDA | Hist Avg | EV/Sales | EV/FCF | Leverage |
|---|---|---|---|---|---|---|---|---|
| CRI | $1.27B | $2.65B | $717.3M | 8.3x | 10.0x | 0.93x | 10.9x | Moderate |
Leverage Analysis
| Company | Net Debt/EBITDA | Hist Avg | Hist Range | Debt % of EV | Leverage Tier |
|---|---|---|---|---|---|
| CRI | 2.24x | 1.43x | 0.44x - 2.42x | 42.6% | Moderate |
7C
DCF & Intrinsic Value Analysis
Carter’s, Inc. (CRI) presents a stark divergence between its current market valuation and its intrinsic DCF value, suggesting a significant disconnect between investor sentiment and fundamental cash flow generation. The valuation environment has shifted dramatically from the low-rate regime of 2015-2021, where Fed Funds rates hovered near zero, to the current 4.48% environment. While rising rates typically compress multiples and increase discount rates, CRI’s weighted average cost of capital (WACC) remains relatively low at 6.21%, supported by a modest beta of 1.06 and tight BAA credit spreads of 1.64%. This low discount rate, when applied to a firm generating $242.6 million in annual free cash flow against a depressed share price, results in an intrinsic value calculation that exceeds $260 per share.
The discrepancy between the Historical DCF ($260.16) and the Analyst DCF ($294.95) stems from differing expectations regarding the company’s recovery trajectory. The Historical DCF relies on a 1.9% 10-year FCF CAGR, which reflects a mature, slow-growth business. In contrast, the Analyst DCF is approximately 13% higher, suggesting that forward-looking estimates anticipate a reversal of the recent -5.7% 5-year FCF CAGR through operational efficiencies or a stabilization in the birth-rate-driven demand cycle. Furthermore, CRI’s aggressive historical buyback rate of 4.3% per year acts as a massive tailwind in these models; by consistently reducing the denominator (shares outstanding), the per-share value is propelled upward at a rate that the market currently refuses to price in. The current market price of $34.73 implies a terminal decline scenario that far exceeds the conservative 3.0% terminal growth rate used in our sector-based analysis.
Key Findings
- The extreme upside in both DCF models (>600%) suggests the market is pricing in a 'value trap' scenario or a structural break in the business that historical cash flows do not yet reflect.
- A consistent 4.3% annual share repurchase program significantly inflates per-share intrinsic value over a 10-year horizon, assuming the company can maintain its current FCF yield.
- Analyst projections are more optimistic than historical trends, implying a belief that the recent 5-year FCF contraction is temporary rather than a permanent impairment of the brand's earning power.
- The current 10Y Treasury rate of 4.26% creates a higher hurdle for valuation than the 2020-2021 era, yet CRI's robust FCF yield remains well above the risk-free rate.
DCF Verdicts by Company
CRI:
Significantly Undervalued. While the DCF suggests an intrinsic value near $260, investors must weigh this against macro headwinds including declining birth rates and shifting retail preferences which may explain the market's severe discount.
Risk-Free Rate (10Y Treasury):
4.26%
Market Risk Premium:
3.14%
BAA Spread:
1.64%
Terminal Growth Rate:
Varies by sector (2.0% - 3.5%)
Methodology Note:
- Market Risk Premium: Calculated dynamically based on credit spreads.
Formula:
ERP = 3.0% + (BAA Spread - 1.5%). When spreads are tight, ERP is lower; when spreads widen, ERP increases. - Terminal Growth Rate: Sector-based assumptions: Technology, Communication Services: 3.5% | Healthcare, Consumer Cyclical: 3.0% | Industrials, Financials, Consumer Defensive, Materials: 2.5% | Energy, Utilities, Real Estate: 2.0%
- Shares Outstanding: Adjusted for historical buyback trends when applicable.
| Company | Current Price | Historical DCF | Upside | Analyst DCF | Upside | Verdict |
|---|---|---|---|---|---|---|
| CRI | $34.73 | $260.16 | +649.1% | $294.95 | +749.3% | Significantly Undervalued |
CRI – Carter's, Inc.
WACC Calculation
| Risk-Free Rate (Rf) | 4.26% |
| Beta (β) | 1.06 |
| Market Risk Premium | 5.50% |
| Cost of Equity (Ke = Rf + β × MRP) | 7.59% |
| Cost of Debt (after-tax) | 4.66% |
| WACC | 6.21% |
Historical Free Cash Flow
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| FCF ($B) | $0.6B | $0.2B | $0.0B | $0.5B | $0.2B |
| FCF Margin (%) | 18.4% | 6.6% | 1.5% | 15.9% | 8.5% |
FCF CAGRs: 5Y: -5.7% | 10Y: 1.9% | Avg FCF Margin (5Y): 10.2%
DCF Valuation (Two Methods)
| Component | Historical Method (10Y CAGR projection) |
Analyst Method (Revenue × FCF Margin) |
|---|---|---|
| Growth Assumption | 3.0% (normalized) (10Y CAGR) | Analyst Revenue Est. × 10.2% margin |
| PV of Projected FCF | $1.16B | $275.6M |
| Terminal Value | $9.42B | $9.39B |
| PV of Terminal Value | $6.97B | $8.85B |
| Enterprise Value | $8.13B | $9.12B |
| (-) Net Debt | $717.3M | $717.3M |
| Equity Value | $7.41B | $8.40B |
| Intrinsic Value per Share | $260.16 | $294.95 |
| vs Current Price ($34.73) | +649.1% | +749.3% |
Sensitivity Analysis (Historical Method)
Intrinsic value per share varying WACC and Terminal Growth Rate
| WACC ↓ / TG → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 4.2% | $407 | $524 | $738 | $1258 | $4381 |
| 5.2% | $272 | $320 | $391 | $504 | $710 |
| 6.2% | $201 | $227 | $261 | $308 | $376 |
| 7.2% | $157 | $173 | $193 | $218 | $251 |
| 8.2% | $128 | $138 | $151 | $166 | $185 |
Current price: $34.73 | Highlighted row shows base case WACC (6.21%)
Verdict:
Significantly Undervalued
(Combined upside: +699.2%, DCF Confidence: Medium)
DCF Summary Comparison
| Company | Current Price | Historical DCF | Analyst DCF | Combined Upside | Verdict |
|---|---|---|---|---|---|
| CRI | $34.73 | $260.16 (+649.1%) | $294.95 (+749.3%) | +699.2% | Significantly Undervalued |
7D
Analyst vs Market Valuation
Carter's, Inc. (CRI) currently presents a challenging valuation profile characterized by a significant disconnect between its market price and fundamental analyst expectations. Trading at $34.73, the stock sits well above the consensus price target of $28.25, implying a projected downside of 18.7%. This bearish outlook is reinforced by a 'Sell' sentiment from the covering analyst, whose most optimistic target ($33.00) remains nearly 5% below the current trading level. For retail investors, this suggests that the market may be pricing in a recovery or stability that professional research does not yet support.
The valuation is further complicated by a lack of breadth in analyst coverage, with only one primary analyst providing estimates. While the price target has trended upward by 8.6% over the past year—moving from $26.71 to a recent $29.00—this adjustment appears to be a reactive trailing of the stock price rather than a shift in fundamental conviction. The convergence of a 'Sell' rating and a price target significantly below the current market price indicates a high-conviction view that the stock is currently overvalued.
Key Findings
- Significant downside risk of 18.7% based on the consensus price target of $28.25 relative to the current price of $34.73.
- Severe P/E expansion from 6.7x TTM to 10.7x Forward, indicating a 61.6% increase in the earnings multiple due to expected EPS contraction.
- Unanimous bearish sentiment with a 'Sell' rating and a target range ($25.00 - $33.00) that sits entirely below the current market price.
Price Target Trend Analysis
Although the price target has evolved upward from $26.71 a year ago to a more recent $29.00, this 8.6% increase has failed to keep pace with the equity's market performance. The rising target trend signals a slight moderation in extreme bearishness, but the fact that the revised target remains nearly 19% below the current price suggests that analysts believe the stock's recent gains are fundamentally unsupported and likely to mean-revert.
P/E Trajectory Analysis
The P/E trajectory for CRI reveals a concerning outlook for earnings quality. The transition from a trailing P/E of 6.7x to a forward P/E of 10.7x represents a 61.6% expansion. In valuation terms, this is typically a negative signal; when the forward P/E is significantly higher than the trailing P/E, it indicates that analysts expect earnings per share to decline sharply. This suggests that CRI is currently a 'value trap' where the low trailing multiple masks a deteriorating bottom line.
Analyst Price Targets
| Company | Current Price | Target Consensus | Target Low | Target High | Upside | Analysts | Sentiment |
|---|---|---|---|---|---|---|---|
| CRI | $34.73 | $28.25 | $25.00 | $33.00 | -18.7% | 1 | Sell |
Price Target Evolution
How analyst targets have changed over time - rising targets signal improving sentiment
| Company | Last Month Avg | Last Quarter Avg | Last Year Avg | Change (M vs Y) | Trend |
|---|---|---|---|---|---|
| CRI | $29.00 (1) | $27.50 (2) | $26.71 (7) | +8.6% | Rising |
Forward Estimates & P/E Comparison
Comparing trailing (TTM) vs forward P/E reveals market expectations for earnings growth
| Company | Forward EPS | Forward Revenue | TTM P/E | Forward P/E | P/E Change | Estimate Year |
|---|---|---|---|---|---|---|
| CRI | $3.23 | $2.87B | 6.7x | 10.7x | +61.6% (Earnings declining) | FY2027 |
Reading P/E Change: Negative change (TTM P/E > Forward P/E) suggests analysts expect earnings growth.
Positive change indicates earnings may decline. Large differences warrant investigation into the growth story.
7E
Valuation Summary & Investment Implications
Carter’s, Inc. (CRI) presents a complex valuation profile characterized by a significant disconnect between its current market price of $34.73 and its median implied fair value of $60.95, representing a potential upside of 75.5%. The analysis reveals a stark divergence between cash-flow-based intrinsic value and near-term market sentiment. While peer-based multiples for earnings (P/E at $82.16) and enterprise value (EV/EBITDA at $63.07) suggest the stock is trading at a deep discount to the broader industry, Wall Street analysts remain notably more conservative with a consensus target of $28.25, implying an 18.7% downside from current levels.
The valuation landscape for CRI is defined by a exceptionally wide range, spanning from $25.64 to $260.16. This variance is primarily driven by a Discounted Cash Flow (DCF) model that yields an outlier value of $260.16. While this suggests immense long-term cash generation potential if margins stabilize, it contrasts sharply with the Price-to-Book (P/B) metric of $25.64, which reflects more sober expectations regarding the company's asset base and current equity risk premium. The convergence of P/S ($58.84) and EV/EBITDA ($63.07) near the median provides a more grounded 'fair value' cluster that supports a bullish mid-term recovery thesis.
Key Takeaways
- Peer-based valuation metrics (P/E, EV/EBITDA, and P/S) consistently indicate that CRI is significantly undervalued relative to its industry cohort, with implied values ranging from $58.84 to $82.16.
- A massive divergence exists between the DCF-implied value ($260.16) and the Analyst Consensus ($28.25), signaling a major disagreement between long-term theoretical cash flow potential and near-term fundamental headwinds.
- The Price-to-Book (P/B) valuation of $25.64 serves as a critical floor, suggesting that in a worst-case re-rating scenario, the stock may have roughly 26% downside risk.
- The median implied value of $60.95 suggests the market is currently mispricing CRI's earnings power by nearly 75%, assuming the company can return to historical peer-average multiples.
Investment Implications
For investors, CRI represents a high-uncertainty, high-reward value play. The wide range of valuation outcomes suggests that while the stock is statistically undervalued based on peer comparisons and cash flow models, it faces significant 'value trap' risks as evidenced by conservative analyst targets. The investment case hinges on whether the market will eventually reward CRI with peer-level multiples or if the company's current discount is a permanent structural adjustment to the shifting retail landscape. Conservative investors may find the 18.7% downside suggested by analysts concerning, while deep-value investors may see the $60.95 median target as a compelling entry point for a long-term turnaround.
Comprehensive Valuation Summary
Aggregated implied values from multiple valuation methods: P/E, P/B, EV/EBITDA, P/S (peer-based), DCF, and Analyst Targets
| Company | Current Price | Valuation Range | Median Value | Median Upside | Methods | Consensus |
|---|---|---|---|---|---|---|
| CRI | $34.73 | $25.64 - $260.16 | $60.95 | +75.5% | 6 | Undervalued |
Valuation Details by Method
Implied values from each valuation methodology for individual companies
CRI – Carter's, Inc.
Current: $34.73
Undervalued
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $82.16 | +136.6% | Peer median P/E (25.4x) × Forward EPS ($3.23) |
| P/B (Peer) | $25.64 | -26.2% | Peer median P/B (1.67x) × Book Value per Share |
| EV/EBITDA (Peer) | $63.07 | +81.6% | Peer median EV/EBITDA (9.2x) × EBITDA - Net Debt |
| P/S (Peer) | $58.84 | +69.4% | Peer median P/S (1.15x) × Revenue per Share |
| DCF | $260.16 | +649.1% | Revenue × FCF Margin projection (normalized FCF) |
| Analyst Target | $28.25 | -18.7% | Consensus of 1 analysts |
| Median | $60.95 | +75.5% | Based on 6 methods |
Most Undervalued
- CRI
Highest Analyst Upside
- CRI